LOGIN
Perioperative Teriparatide vs Denosumab for Junctional Complications
November 2025
Perioperative Teriparatide vs Denosumab for Junctional Complications
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
Osteoporos Int . 2025 May;36(5):833-843.Synopsis
Sixty-four postmenopausal women with osteoporosis undergoing adult spinal deformity surgery were randomized to receive perioperative teriparatide (n=32) or denosumab (n=32). The primary outcome of interest was the incidence of proximal junctional kyphosis (PJK) and proximal junctional failure (PJF) within 12 months after surgery. Secondary outcomes of interest included changes in hip bone mineral ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.